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Background: In 2013, 6.1 million tuberculosis (TB) cases were
reported to WHO. Of these, 5.7 million were people newly diag-
nosed and another 0.4millionwere already on treatment. Globally,
3.5%ofnewand20.5%ofpreviously treatedTBcaseswereestimated
to have hadmultidrug resistant (MDR) - TB. The previous treatment
for TB is the strongest risk factor for development of MDR-TB. The
current scenario states that even treatment naïve patients are also
at risk.
Methods & Materials: The study was a prospective observa-
tional study aimed to identify the group at high riskwas carried out
over a period of 9months in govt. hospitals in the Telangana region.
The patients were enrolled based on the MDR-TB suspect crite-
ria: failure, S+ at 4th month (retreatment case), contact of known
MDR-TB case, S+ at diagnosis (retreatment case), any follow up S+,
S- at diagnosis (retreatment case), and HIV-TB case. Results were
analyzed using ﬁsher’s exact test.
Results: Among 2033 suspected MDR-TB patients, 453 (22%)
showed resistance to isoniazid/rifampicin or isoniazid and
rifampicin. Out of 453, 199 (43%) were resistant to Isoniazid, 173
(38%) were resistant to both Isoniazid and rifampicin, and 81 (17%)
were resistant to rifampicin. Patients aging <45 years (76%) and
>45 years (23%) were found to be at equal risk (p=0.085). Analyzing
453 MDR-TB cases, males (78%) were found to be at higher risk to
develop MDR-TB (p=0.002). But if we consider the whole suspect
population (2033), out of 1641 male suspected cases, 355 (21%)
were diagnosed with MDR-TB and out of 392 female suspected
cases, 98 (25%) were diagnosed with MDR-TB. This clearly states
that both genders are at equal risk. Among 453 suspected cases, S+
at diagnosis-retreatment case (291) were found to be at high risk
followed by any follow up S+ (84) and HIV TB case (32).
Conclusion: The study concluded that each and every suspect
individual is at equal risk to develop MDR-TB. The high level of
signiﬁcance in risk of developingMDR-TB directs this study further
to check for the strategies to reduce the rate of TB and MDR.
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Background: Measles continues to be a major cause globally of
childhoodmorbidity andmortality andwas responsible for 145,700
deaths worldwide in 2013. Many countries have now adopted
measles elimination targets including China, which was originally
slated for elimination in 2012 as part of the WHO’s Western Paciﬁc
Region measles control plan. This elimination goal was not met
despite China’s intensive control efforts over several years, and
sustained levels of transmission continue to characterize measles
epidemiology there. In order to better understand measles suscep-
tibility in Tianjin, China, the University ofMichigan School of Public
Health and the Tianjin Centers for Diseases Control collaborated on
a large, population-based, cross-sectional, seroprevalence and case
control study conducted throughout the municipality with a spe-
cial focus on documenting the serostatus of mother-infants pairs.
Infants play a major role in ongoing disease transmission in China
even though measles vaccination is provided free at age 8 months.
Methods & Materials: We interviewed and drew dried blood
spots (DBS) from a systematic random sample of 2818 people from
every Tianjin district, including 809 mother/infant pairs. The DBS
were tested for measles IgG to determine measles susceptibility.
Results: While the majority of mothers (81.5%) tested IgG pos-
itive only 16.3% of all infants less than 8 months of age tested IgG
positive. Among infants one month of age or less, only 40.3% were
IgG positive. That level of IgG positivity dropped to 12.3% at age 3
months, 6% at age 5 months; no infants were IgG positive by age
7 months. There was no signiﬁcant difference in in the percentage
of infants with a measles positive IgG result by birthweight, rural
vs urban district, or mother’s vaccination status, education and age
group. Infants ofmother’swith a history ofmeasles infection and of
motherswho are non-residents had a higher percentage ofmeasles
IgG positivity.
Conclusion: Although waning maternal measles antibodies in
infants is well-documented, we found this may be occurring at
younger ages than previously documented. This could have major
implications for measles elimination programs in China and glob-
ally requiring new strategies to target transmission in this age
group.
http://dx.doi.org/10.1016/j.ijid.2016.02.499
